CO5080775A1 - Tratamiento de enfermedad viral en cerdos - Google Patents
Tratamiento de enfermedad viral en cerdosInfo
- Publication number
- CO5080775A1 CO5080775A1 CO99012471A CO99012471A CO5080775A1 CO 5080775 A1 CO5080775 A1 CO 5080775A1 CO 99012471 A CO99012471 A CO 99012471A CO 99012471 A CO99012471 A CO 99012471A CO 5080775 A1 CO5080775 A1 CO 5080775A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- imf
- jpeg
- halo
- emi file
- Prior art date
Links
- 241000282887 Suidae Species 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 3
- -1 cyano, ethylenedioxy, benzyl Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 125000006413 ring segment Chemical group 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7646698P | 1998-03-02 | 1998-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5080775A1 true CO5080775A1 (es) | 2001-09-25 |
Family
ID=22132217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO99012471A CO5080775A1 (es) | 1998-03-02 | 1999-03-01 | Tratamiento de enfermedad viral en cerdos |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6034070A (https=) |
| EP (1) | EP0948967B1 (https=) |
| JP (1) | JP4555472B2 (https=) |
| AT (1) | ATE281173T1 (https=) |
| AU (1) | AU2979899A (https=) |
| CA (1) | CA2322327C (https=) |
| CO (1) | CO5080775A1 (https=) |
| DE (1) | DE69921530T2 (https=) |
| DK (1) | DK0948967T3 (https=) |
| ES (1) | ES2230802T3 (https=) |
| MY (1) | MY124071A (https=) |
| PT (1) | PT948967E (https=) |
| SI (1) | SI0948967T1 (https=) |
| TW (1) | TW565452B (https=) |
| WO (1) | WO1999044619A1 (https=) |
| ZA (1) | ZA991641B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6506885B1 (en) * | 2001-09-27 | 2003-01-14 | The United States Of America As Represented By The Secretary Of Agriculture | Monoclonal antibodies to the drug tilmicosin and a method for detecting the same |
| US6946137B2 (en) * | 2001-10-19 | 2005-09-20 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
| ES2561108T3 (es) * | 2001-10-19 | 2016-02-24 | Idexx Laboratories, Inc. | Composiciones inyectables para la liberación controlada de compuesto farmacológicamente activo |
| SI1483251T1 (sl) | 2002-03-12 | 2010-03-31 | Bristol Myers Squibb Co | C cian epotilonski derivati |
| US7282487B2 (en) * | 2004-10-28 | 2007-10-16 | Idexx Laboratories | Method for treating bacterial infections in horses or pigs with tilmicosin |
| CA2657483C (en) | 2006-07-28 | 2012-10-09 | Intervet International B.V. | Macrolide synthesis process |
| CN103288904B (zh) * | 2013-06-28 | 2015-07-15 | 宁夏泰瑞制药股份有限公司 | 一种磷酸替米考星晶体的制备方法 |
| CN103483406A (zh) * | 2013-09-25 | 2014-01-01 | 宁夏泰瑞制药股份有限公司 | 一种磷酸替米考星的制备方法 |
| CN103923141B (zh) * | 2014-04-21 | 2016-04-27 | 西南大学 | 一种依托替米考星的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820695A (en) * | 1982-09-13 | 1989-04-11 | Eli Lilly And Company | C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics |
| AU561147B2 (en) * | 1982-09-13 | 1987-04-30 | Eli Lilly And Company | 20-amino macrolide antibiotics |
| US5574020A (en) * | 1989-09-28 | 1996-11-12 | Eli Lilly And Company | Tilmicosin formulation |
| US5695766A (en) * | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
| GB2289279B (en) * | 1994-05-13 | 1998-09-16 | Iberica Cyanamid | Diagnostic kits and vaccines containing recombinant PRRSV proteins |
| EP0732340B1 (en) * | 1995-03-14 | 2004-06-09 | Akzo Nobel N.V. | Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
-
1999
- 1999-03-01 ZA ZA9901641A patent/ZA991641B/xx unknown
- 1999-03-01 AT AT99301503T patent/ATE281173T1/de active
- 1999-03-01 EP EP99301503A patent/EP0948967B1/en not_active Expired - Lifetime
- 1999-03-01 PT PT99301503T patent/PT948967E/pt unknown
- 1999-03-01 DK DK99301503T patent/DK0948967T3/da active
- 1999-03-01 SI SI9930730T patent/SI0948967T1/xx unknown
- 1999-03-01 ES ES99301503T patent/ES2230802T3/es not_active Expired - Lifetime
- 1999-03-01 CO CO99012471A patent/CO5080775A1/es unknown
- 1999-03-01 MY MYPI99000736A patent/MY124071A/en unknown
- 1999-03-01 DE DE69921530T patent/DE69921530T2/de not_active Expired - Lifetime
- 1999-03-01 TW TW088103069A patent/TW565452B/zh not_active IP Right Cessation
- 1999-03-01 US US09/259,780 patent/US6034070A/en not_active Expired - Lifetime
- 1999-03-02 WO PCT/US1999/004621 patent/WO1999044619A1/en not_active Ceased
- 1999-03-02 JP JP2000534220A patent/JP4555472B2/ja not_active Expired - Fee Related
- 1999-03-02 AU AU29798/99A patent/AU2979899A/en not_active Abandoned
- 1999-03-02 CA CA002322327A patent/CA2322327C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0948967B1 (en) | 2004-11-03 |
| WO1999044619A1 (en) | 1999-09-10 |
| AU2979899A (en) | 1999-09-20 |
| JP4555472B2 (ja) | 2010-09-29 |
| ZA991641B (en) | 2000-09-01 |
| EP0948967A3 (en) | 1999-10-20 |
| DE69921530D1 (de) | 2004-12-09 |
| DE69921530T2 (de) | 2005-10-27 |
| PT948967E (pt) | 2005-02-28 |
| SI0948967T1 (en) | 2005-06-30 |
| ES2230802T3 (es) | 2005-05-01 |
| ATE281173T1 (de) | 2004-11-15 |
| TW565452B (en) | 2003-12-11 |
| MY124071A (en) | 2006-06-30 |
| EP0948967A2 (en) | 1999-10-13 |
| CA2322327C (en) | 2009-12-22 |
| US6034070A (en) | 2000-03-07 |
| CA2322327A1 (en) | 1999-09-10 |
| JP2002505294A (ja) | 2002-02-19 |
| DK0948967T3 (da) | 2005-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5080775A1 (es) | Tratamiento de enfermedad viral en cerdos | |
| PE20010126A1 (es) | Pirrolotriazinas como inhibidores de cinasas | |
| CO5210864A1 (es) | Nuevos derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina | |
| CO5180581A1 (es) | Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia | |
| AR029773A1 (es) | Un metodo para inhibir la polimerizacion prematura de monomeros etilenicamente insaturados y una composicion de un monomero etilenicamente insaturado preparada con el mismo | |
| MX166092B (es) | Composicion de cemento con resistencia mejorada y procedimiento para aumentar la resistencia de mezclas de cementos hidraulicos | |
| SV1993000080A (es) | Derivados de n4-(oxicarbonil substituidos)-5'-desoxi-5-fluorocitidina ref. ran 4060/166 | |
| ES2149350T3 (es) | Compuestos y liposomas farmaceuticamente activos y metodos para su utilizacion. | |
| CO5261616A1 (es) | Inhibidores no peptidicos de la union celular dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias | |
| CO5271665A1 (es) | (compuestos de pirrolo [2,3-d] pirimidina | |
| ES2193356T3 (es) | Procedimiento para la preparacion de copolimeros de propileno aleatorios y productos obtenidos de estos. | |
| PE47496A1 (es) | Compuesto de naftilo, intermedio y procedimiento de preparacion | |
| CO5300408A1 (es) | Cubierta de seguridad para aguja | |
| MX9307808A (es) | Composiciones que contienen organopolisiloxanos, autodispersables en agua. | |
| AR027218A1 (es) | Inhibicion de polimerizacion de monomeros insaturados | |
| ES2073246T3 (es) | Derivados de pirazina. | |
| CO5200778A1 (es) | Composicion farmaceutica que comprende una cantidad terapeuticamente efectiva de b enzimidazol, administrada para prevenir y tratar el cancer e inhibir la metastasis | |
| PE20011318A1 (es) | Compuestos fenilo sustituidos inhibidores de la farnesiltransferasa | |
| GT200100251A (es) | Procedimiento para la preparacion de imidazotriazinonas substituidas con sulfonamida | |
| CO5261596A1 (es) | Derivados de cromano como compuestos estrogenicos, y su uso en la fabricacion de medicamentos para tratamientos relaionados con los receptores de estrogenos | |
| AR025296A1 (es) | MÉTODO PARA INHIBIR LA POLIMERIZACIoN PREMATURA DE MONoMEROS VINIL AROMÁTICOS Y COMPOSICIoN DE MONoMEROS VINIL AROMÁTICOS Y DEL INHIBIDOR. | |
| CO5601010A2 (es) | Derivados de oxazolidinona, procesos para su preparacion y composiciones farmaceuticas que los contienen | |
| CO5390081A1 (es) | Compuestos organicos | |
| CO5221087A1 (es) | Pesticidas/depsipeptidos | |
| CO5170492A1 (es) | Estabilizacion de isotiazolona |